Itziar San-José

Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study

Virginia Pérez‐Grijalba, Judith Romero, Pedro Pesini et al. · The Journal of Prevention of Alzheimer s Disease · 2019 · 125 citations · Full text

Life Sciences, Neurology, Neuroscience +10

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

Ana-María Lacosta, María Pascual‐Lucas, Pedro Pesini et al. · Alzheimer s Research & Therapy · 2018 · 110 citations · Full text

Veterinary Medicine, Geriatric Medicine, Immunology +17

Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

Virginia Pérez‐Grijalba, Javier Arbizu, Judith Romero et al. · Alzheimer s Research & Therapy · 2019 · 58 citations · Full text

Medicine, Neurology, Neuroscience +17

Reliable Measurements of the<i>β</i>-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD

Pedro Pesini, Virginia Pérez‐Grijalba, Inmaculada Monleón et al. · International Journal of Alzheimer s Disease · 2012 · 52 citations · Full text

Medicine, Neurology, Neuroscience +17

Several Direct and Calculated Biomarkers from the Amyloid-β Pool in Blood are Associated with an Increased Likelihood of Suffering from Mild Cognitive Impairment

Virginia Pérez‐Grijalba, Pedro Pesini, Inmaculada Monleón et al. · Journal of Alzheimer s Disease · 2013 · 19 citations · Full text

Medicine, Neurology, Neuroscience +10